Abstract
Hepatic oval cells (HOCs) are thought to possess self‑renewal ability and a bipotential capacity for differentiation, which allows them to differentiate into hepatocytes and cholangiocytes. Autophagy serves an important role in self‑renewal and differentiation of stem cells; however, how autophagy contributes to proliferation and differentiation of hepatic progenitor cells has yet to be elucidated. In the present study, autophagy was regulated by rapamycin (Rapa) and chloroquine (Chlo) administration. The results demonstrated that Chlo‑treated HOCs exhibited decreased autophagic activity alongside a decreased tendency to proliferate, as determined by Cell Counting Kit‑8. In addition, activation of autophagy by Rapa enhanced the biliary differentiation of HOCs. Furthermore, increased phosphorylated (p)‑extracellular signal‑regulated kinase (ERK)/p‑p38 expression was observed following the induction of autophagy, thus indicating that the mitogen‑activated protein kinase (MAPK)/ERK signaling pathway was activated by autophagy to exert effects on the stimulation of HOC proliferation and differentiation. In conclusion, the present study demonstrated that autophagy regulates proliferation and biliary differentiation of HOCs via the MAPK/ERK signaling pathway. These results suggest a role for autophagy in stimulating the proliferation and differentiation of HOCs.
Introduction
Hepatic oval cells (HOCs) act as the liver's "emergency backup" stem cells. Activated when severe damage prevents normal hepatocyte regeneration, these bipotential cells can differentiate into either hepatocytes or cholangiocytes (bile duct cells). While HOCs are vital for recovery from chronic liver disease, the mechanisms governing their proliferation and differentiation are not fully understood. Autophagy, the cell’s internal recycling system, is known to maintain stem cell health. This study investigates the specific role of autophagy in HOC proliferation and biliary differentiation, identifying the underlying signaling pathways.
Methods
The researchers utilized the WB-F344 rat hepatic oval cell line. Autophagy was pharmacologically modulated using:
- Rapamycin (Rapa): To induce autophagic activity.
- Chloroquine (Chlo): To inhibit autophagic flux.
- Sodium butyrate (SB): To induce biliary differentiation.
Outcomes were measured via CCK-8 assays (viability), flow cytometry (cell cycle/apoptosis), and Western blotting for markers like CK19 (biliary), LC3/p62 (autophagy), and phosphorylated ERK/p38 (signaling).
Key Results
Autophagy is Essential for HOC Proliferation
Inhibiting autophagy with Chloroquine significantly decreased HOC proliferation in a dose- and time-dependent manner. Flow cytometry revealed that blocking autophagy triggered apoptosis and arrested the cell cycle, particularly increasing the subG1 population, which represents apoptotic cells.
Driving Biliary Differentiation
While HOCs are bipotential, the induction of autophagy specifically promoted their differentiation into the biliary lineage. In cells treated with sodium butyrate, the addition of Rapamycin significantly increased the expression of the biliary marker CK19 compared to controls.
The MAPK/ERK Signaling Mechanism
The study identified the MAPK/ERK signaling pathway as the mediator of these effects. Autophagy induction via Rapamycin led to a ~2-fold increase in the phosphorylation of ERK1/2 and p38. This suggests that autophagy acts as an upstream trigger for the MAPK/ERK pathway, which then coordinates HOC growth and differentiation.
Conclusion
This research identifies autophagy as a master regulator of HOC fate. By activating the MAPK/ERK pathway, autophagy drives both the expansion of the HOC pool and their differentiation into the biliary lineage. These findings provide a potential molecular target for enhancing liver regeneration, although further in vivo studies are required to validate these mechanisms in a complex physiological environment and to assess the risks of potential tumorigenesis.
Summary updated